{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:56:38Z","timestamp":1793325398484,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2242017K41024"],"award-info":[{"award-number":["2242017K41024"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21571033"],"award-info":[{"award-number":["21571033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503099"],"award-info":[{"award-number":["81503099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bbrc.2019.10.184","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:20:37Z","timestamp":1572999637000},"page":"753-761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Emerging JWA-targeted Pt(IV) prodrugs conjugated with CX-4945 to overcome chemo-immune-resistance"],"prefix":"10.1016","volume":"521","author":[{"given":"Feihong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6469-7869","authenticated-orcid":false,"given":"Shaohua","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.10.184_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrc749","article-title":"DNA and its associated processes as targets for cancer therapy","volume":"2","author":"Laurence","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2019.10.184_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/1568026043387313","article-title":"From DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation","volume":"4","author":"Baruah","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbrc.2019.10.184_bib3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2006.07.007","article-title":"DNA damage-induced cell death by apoptosis","volume":"12","author":"Wynand","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2019.10.184_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.canlet.2012.01.007","article-title":"DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis","volume":"332","author":"Wynand","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2019.10.184_bib5","doi-asserted-by":"crossref","first-page":"15216","DOI":"10.1002\/chem.201404090","article-title":"Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand","volume":"20","author":"Zhao","year":"2014","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.bbrc.2019.10.184_bib6","first-page":"131","article-title":"Jana Kasparkova, Modifications of DNA by platinum complexes relation to resistance of tumors to platinum antitumor drugs","volume":"8","author":"Viktor","year":"2005","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2019.10.184_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2016.10.026","article-title":"A\u00a0CK2-targeted Pt (IV) prodrug to disrupt DNA damage response","volume":"385","author":"Chen","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2019.10.184_bib8","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/nar\/gkp1149","article-title":"CK2 phosphorylation-dependent interaction between aprataxin and MDC1 in the DNA damage response","volume":"38","author":"Becherel","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2019.10.184_bib9","doi-asserted-by":"crossref","first-page":"10288","DOI":"10.1158\/0008-5472.CAN-10-1893","article-title":"CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy","volume":"70","author":"Siddiqui-Jain","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2019.10.184_bib10","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.freeradbiomed.2007.02.018","article-title":"Identification of JWA as a novel functional gene responsive to environmental oxidative stress induced by benzo[a]- pyrene and hydrogen peroxide","volume":"42","author":"Chen","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbrc.2019.10.184_bib11","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/nar\/gkp054","article-title":"JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative stress-induced DNA single-strand breaks","volume":"37","author":"Wang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2019.10.184_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbrc.2019.10.184_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2019.10.184_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/jnci\/91.11.933","article-title":"Defective DNA repair in cells with human T-cell leukemia\/bovine leukemia viruses: role of tax gene","volume":"91","author":"Philpott","year":"1999","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2019.10.184_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1383-5718(97)00091-0","article-title":"Detection of DNA lesions induced by chemical mutagens using the single-cell gel electrophoresis (comet) assay. 2. Relationship between DNA migration and alkaline condition","volume":"393","author":"Miyamae","year":"1997","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbrc.2019.10.184_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0300-483X(03)00289-0","article-title":"Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage","volume":"193","author":"Izumi","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.bbrc.2019.10.184_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tcb.2009.10.002","article-title":"Transcription-independent P53 apoptosis: an alternative route to death","volume":"20","author":"Speidel","year":"2010","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbrc.2019.10.184_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-4020-6554-5_3","article-title":"The mitochondrial death pathway","volume":"615","author":"Chalah","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbrc.2019.10.184_bib19","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.2174\/1381612823666170201161037","article-title":"Recent approaches to platinum(IV) prodrugs: a variety of strategies for enhanced delivery and efficacy","volume":"23","author":"Najjar","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.bbrc.2019.10.184_bib20","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2019.10.184_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrc2090","article-title":"Inflammation in prostate carcinogenesis","volume":"7","author":"Angelo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2019.10.184_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.critrevonc.2018.03.016","article-title":"Investigational agents to enhance the efficacy of chemotherapy or radiation in pancreatic cancer","volume":"126","author":"Myrna","year":"2018","journal-title":"Crit. Rev. Oncol.-Hematol."},{"key":"10.1016\/j.bbrc.2019.10.184_bib23","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1158\/0008-5472.CAN-15-1885","article-title":"Agonist-mediated activation of STING induces apoptosis in malignant B cells","volume":"76","author":"Tang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2019.10.184_bib24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1932100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1932100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:27:31Z","timestamp":1777382851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1932100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0006291X1932100X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.184","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging JWA-targeted Pt(IV) prodrugs conjugated with CX-4945 to overcome chemo-immune-resistance","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}